Amount payable under the service agreement, classified as current.

No definition available.

Name:	snpx_AccountsPayableForServiceAgreementCurrent
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Additional extension periods for the agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	snpx_AdditionalExtensionPeriodsOfAgreement
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Term of the agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	snpx_AgreementTerm
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of business days prior to the end of the Initial Term or Renewal Term notice required for agreement termination.

+ References

No definition available.

+ Details

Name:	snpx_AgreementTerminationNumberOfBusinessDaysNotice
Namespace Prefix:	snpx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount stated the total trial cost.

+ References

No definition available.

+ Details

Name:	snpx_AmountFundedAgainstTotalTrialCost
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The amount of award received to support an additional phase 2.

+ References

No definition available.

+ Details

Name:	snpx_AmountOfAwardReceived
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of annual consulting fee.

+ References

No definition available.

+ Details

Name:	snpx_AnnualConsultancyAgreementFees
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Maximum percentage of base salary payable as annual discretionary bonus to the employee.

+ References

No definition available.

+ Details

Name:	snpx_AnnualDiscretionaryBonusPayableMaximumPercent
Namespace Prefix:	snpx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Represents information pertaining to charges incurred by the company.

+ References

No definition available.

+ Details

Name:	snpx_ChargesIncurred
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of consulting fees incurred during the period.

+ References

No definition available.

+ Details

Name:	snpx_ConsultancyFees
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of monthly installment of annual consulting fee.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementMonthlyInstallmentFee
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the notice term for cancellation.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementNoticeForCancellation
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the notice term for cancellation for material breach.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementNoticeForCancellationForMaterialBreach
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the amount of payments for consulting.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementPaymentsForConsulting
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Renewal term of consulting agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementRenewalTerm
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the term of consulting agreement.

+ References

No definition available.

+ Details

Name:	snpx_ConsultingAgreementTerm
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Period between issuance and maturity of long-term debt, in commencement over which fixed contract payments are due per the terms of an agreement.

+ References

No definition available.

+ Details

Name:	snpx_ContractPaymentsTerm
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the estimated budget for services.

+ References

No definition available.

+ Details

Name:	snpx_EstimatedBudgetForServices
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Extension periods for the agreement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	snpx_ExtensionPeriodsForAgreement
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of initial annual base salary payable to the employee.

+ References

No definition available.

+ Details

Name:	snpx_InitialAnnualBaseSalaryPayable
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Options granted to the employee to purchase shares of common stock as a minimum percent of Company's outstanding shares of common stock immediately following the Spin-Off.

+ References

No definition available.

+ Details

Name:	snpx_OptionsGrantedAsMinimumPercentOfCompanySOutstandingSharesOfCommonStockImmediatelyFollowingSpinOff
Namespace Prefix:	snpx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of prepayments under the service agreement, classified as current.

+ References

No definition available.

+ Details

Name:	snpx_PrepaymentsForServiceAgreementCurrent
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount of proceeds from grants during the period.

+ References

No definition available.

+ Details

Name:	snpx_ProceedsFromGrants
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Represents the target enrollment of study subjects.

+ References

No definition available.

+ Details

Name:	snpx_TargetEnrollmentOfStudySubjects
Namespace Prefix:	snpx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

It represents the amount of fair value portion of warrants.

+ References

No definition available.

+ Details

Name:	snpx_WarrantFairValueDisclosure
Namespace Prefix:	snpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Warrants term following the effective date, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

No definition available.

+ Details

Name:	snpx_WarrantsAndRightsOutstandingTermFollowingEffectiveDate
Namespace Prefix:	snpx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Warrant exercise price expressed as percentage of closing price of common stock.

+ References

No definition available.

+ Details

Name:	snpx_WarrantsExercisePriceAsPercentageOfSharePrice
Namespace Prefix:	snpx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(3)(a)(4))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_GrantsReceivableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(2)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The risk-free interest rate assumption that is used in valuing an option on its own shares.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Gross number of share options (or share units) granted during the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(1)(iv)(01)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

+ Details

Name:	us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Aggregate value of stock related to Restricted Stock Awards issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644

+ Details

Name:	us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

+ Details

Name:	us-gaap_WarrantsAndRightsOutstandingMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258

+ Details

Name:	us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ConsultingAgreementWithKatalystSecuritiesLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ConsultingAgreementWithGpNurmenkariIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ServicesAgreement2020Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=snpx_NationalInstitutesOfHealthMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ServicesAgreement2022Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ConsultingAgreementWithSherwoodVenturesLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_EmploymentAgreementWithAlanJ.TuchmanM.dMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=snpx_ConsultingAgreementWithSmCapitalManagementLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Other Commitments (Details)																	1 Months Ended				12 Months Ended
Other Commitments (Details)	Oct. 07, 2022 USD ($)	Aug. 04, 2022	Jul. 07, 2022 USD ($) D $ / shares shares	May 12, 2022 item	Feb. 10, 2022 USD ($)	Jan. 01, 2022 USD ($)	Dec. 07, 2021 USD ($)	Jul. 01, 2021 USD ($) $ / shares shares	Jan. 01, 2021 USD ($)	Dec. 07, 2020 USD ($) shares	Dec. 01, 2020 shares	Nov. 30, 2020 USD ($) shares	Jul. 23, 2020 USD ($)	Feb. 01, 2020 USD ($)	Jun. 01, 2019 USD ($)	Aug. 04, 2016 USD ($)	Nov. 30, 2022 USD ($) $ / shares shares	Oct. 31, 2022 USD ($) $ / shares shares	Nov. 30, 2020 USD ($) shares	Apr. 30, 2020 USD ($)	Dec. 31, 2022 USD ($) Y $ / shares shares	Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)	Jan. 22, 2022 USD ($)	Jan. 03, 2022 $ / shares shares	Oct. 31, 2021 $ / shares shares	Oct. 01, 2021 $ / shares shares	Jun. 30, 2021 $ / shares	Apr. 30, 2021 USD ($)	Apr. 01, 2021 $ / shares shares	Feb. 16, 2021 $ / shares shares	Jan. 31, 2021 $ / shares
Other Commitments
Clinical trial expenses																					$ 6,324,928	$ 4,336,414
Exercise price of warrants \| $ / shares																					$ 11.79							$ 0.01				$ 0.01
Number of options granted \| shares																					538,000
Options exercisable period																					9 years 3 months 18 days
Volatility
Other Commitments
Warrants, measurement input																					127.7
Risk-free interest rate
Other Commitments
Warrants, measurement input																					0.72
Expected term
Other Commitments
Warrants term																					5 years
Dividend Yield
Other Commitments
Warrants, measurement input																					0
Consulting Agreement with Katalyst Securities LLC
Other Commitments
Monthly installment of annual consulting fee						$ 10,000			$ 20,000
Consultancy fees																					$ 171,283	590,724
Warrants term											5 years
Warrants to purchase shares of common stock \| shares								4,500			4,500														4,500		4,500			4,500	25,000
Warrants term following the effective date											3 months
Exercise price of warrants \| $ / shares								$ 9.76																	$ 8.69		$ 9.30			$ 8.80	$ 11.46
Consulting Agreement with Katalyst Securities LLC \| Expected term
Other Commitments
Warrants, measurement input \| Y																					5
Consulting Agreement with Katalyst Securities LLC \| Dividend Yield
Other Commitments
Warrants, measurement input																					0
Consulting Agreement with GP Nurmenkari, Inc
Other Commitments
Monthly installment of annual consulting fee						$ 10,000		$ 20,000	$ 12,000					$ 17,500
Consultancy fees																					$ 180,320	401,039
Warrants to purchase shares of common stock \| shares								5,800				2,500							2,500						5,800	5,800	5,800			2,500	10,000
Warrants term following the effective date												3 months
Exercise price of warrants \| $ / shares								$ 9.76																	$ 8.69	$ 9.30				$ 8.80	$ 11.46
2020 Services Agreement
Other Commitments
Amount funded against the total trial cost					$ 1,000,000.0																			$ 1,400,000
Total estimated budget for the services													$ 9,300,000								11,000,000.0
Threshold period of prior written notice to terminate agreement													60 days
Clinical trial expenses																					3,400,000	5,200,000
WCT prepayments included as a prepaid expense and other current assets																					166,000
WCT payments included in accounts payable																					397,000
Charges Incurred					$ 0
2020 Services Agreement \| National Institutes of Health
Other Commitments
Total estimated budget for the services													$ 8,300,000
Amount of award received													2,700,000								2,700,000
Funding received																				$ 1,000,000.0
Funding receivable in year two																													$ 1,700,000
Clinical trial expenses													$ 10,200,000								10,100,000
2022 Services Agreement
Other Commitments
Target enrollment of study subjects \| item				12
Total estimated budget for the services																					2,000,000.0
Threshold period of prior written notice to terminate agreement				90 days
WCT prepayments included as a prepaid expense and other current assets																					202,000
WCT payments included in accounts payable																					123,000
Threshold period to terminate agreement due to material breach				30 days
2022 Services Agreement \| National Institutes of Health
Other Commitments
Clinical trial expenses																					1,400,000
Consulting Agreement With Sherwood Ventures LLC
Other Commitments
Monthly installment of annual consulting fee	$ 30,000		$ 30,000
Consultancy fees																					$ 491,000
Payments for consulting per month			$ 90,000														$ 30,000	$ 30,000
Warrants term																					5 years
Warrants to purchase shares of common stock \| shares			15,459									4,795					4,795	4,659	4,795
Exercise price of warrants \| $ / shares			$ 13.26														$ 14.10	$ 14.54
Number of restricted shares issued \| shares			30,303														7,092	6,878
Amount of restricted shares issued	50,000		$ 150,000														$ 50,000	$ 50,000	$ 50,000
Consulting agreement term			3 months
Agreement renewal term			1 month
Agreement termination, number of business days \| D			5
Fair value of issuance	$ 25,000		$ 75,000									$ 25,000					$ 25,000		$ 25,000				$ 25,000
Warrants exercise price (as a percentage)	100.00%
Number of options granted \| shares										12,575
Options exercisable period							10 years
Vesting period							1 year
Consulting Agreement With Sherwood Ventures LLC \| Volatility
Other Commitments
Warrants, measurement input			112.75														112.75				112.75
Consulting Agreement With Sherwood Ventures LLC \| Risk-free interest rate
Other Commitments
Warrants, measurement input			3.05									4.39					4.39		4.39				4.14
Employment agreement with Alan J. Tuchman, M.D
Other Commitments
Initial annual base salary										$ 222,000
Annual discretionary bonus payable (as a percent)										50.00%
Options granted to purchase shares of common stock as a percent of Company's outstanding shares of common stock immediately following the Spin-Off																																1.00%
Term of agreement										1 year
Extension periods of agreement										6 months
Additional extension period of agreement		6 months
Volatility							129.94%
Risk-free interest rate							0.48%
Fair value of options							$ 106,759
Consulting Agreement with SM Capital Management, LLC
Other Commitments
Contract payments, term																1 year
Annual consulting fee																$ 120,000
Monthly installment of annual consulting fee																$ 10,000
Consultancy fees																					$ 120,000	$ 120,000
Payments for consulting per month															$ 25,000